A psychiatry journal has retracted a 2011 paper exploring the use of ketamine to treat patients with severe depression following an investigation at Yale University. According to the retraction notice, Yale determined that the paper, published in the International Journal of Neuropsychopharmacology, did not accurately describe the research. But the study’s lead author, Gregory Larkin, […]

The post Ketamine-depression paper retracted following investigation at Yale appeared first on Retraction Watch.